RetinalGenix Financial Statements From 2010 to 2026
| RTGN Stock | USD 3.20 0.00 0.00% |
Check RetinalGenix Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RetinalGenix Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . RetinalGenix financial statements analysis is a perfect complement when working with RetinalGenix Technologies Valuation or Volatility modules.
RetinalGenix |
RetinalGenix Technologies OTC Stock Return On Asset Analysis
RetinalGenix Technologies' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current RetinalGenix Technologies Return On Asset | -49.71 |
Most of RetinalGenix Technologies' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RetinalGenix Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, RetinalGenix Technologies has a Return On Asset of -49.709. This is much higher than that of the Healthcare sector and 174.64% higher than that of the Medical Devices industry. The return on asset for all United States stocks is notably higher than that of the company.
RetinalGenix Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RetinalGenix Technologies's current stock value. Our valuation model uses many indicators to compare RetinalGenix Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RetinalGenix Technologies competition to find correlations between indicators driving RetinalGenix Technologies's intrinsic value. More Info.RetinalGenix Technologies is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value RetinalGenix Technologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RetinalGenix Technologies' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About RetinalGenix Technologies Financial Statements
RetinalGenix Technologies investors utilize fundamental indicators, such as revenue or net income, to predict how RetinalGenix OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC. Retinalgenix Technologies operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Pair Trading with RetinalGenix Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RetinalGenix Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RetinalGenix Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with RetinalGenix OTC Stock
Moving against RetinalGenix OTC Stock
| 0.85 | STE | STERIS plc | PairCorr |
| 0.78 | FYBR | Frontier Communications Sell-off Trend | PairCorr |
| 0.75 | SANM | Sanmina | PairCorr |
| 0.73 | EW | Edwards Lifesciences Corp | PairCorr |
| 0.72 | WSFS | WSFS Financial | PairCorr |
The ability to find closely correlated positions to RetinalGenix Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RetinalGenix Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RetinalGenix Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RetinalGenix Technologies to buy it.
The correlation of RetinalGenix Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RetinalGenix Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RetinalGenix Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RetinalGenix Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in RetinalGenix OTC Stock
RetinalGenix Technologies financial ratios help investors to determine whether RetinalGenix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RetinalGenix with respect to the benefits of owning RetinalGenix Technologies security.